Vitality Watch

Dossier pubmed observational 01-aug-2026
Human cohort, case-control, or epidemiological association

Construction and Validation of Plasma Protein-Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles.

Key claim: Two plasma protein-based musculoskeletal aging clocks (MSKAge and MSKAgeMort) built from 39 proteins in 21,070 UK Biobank participants predict mortality and musculoskeletal disease risk and identify genetic and environmental determinants of accelerated musculoskeletal aging.

Abstract

The musculoskeletal system is key to aging. Nonetheless, existing protein-based musculoskeletal aging clocks have limited predictive performance and fail to characterize genetic or environmental determinants. We first constructed a musculoskeletal protein pool by integrating transcriptomic enrichment, protein functional annotation, and literature expertise. Two musculoskeletal aging clocks-MSKAge and MSKAgeMort-were then developed using proteomic data of 21,070 UK Biobank participants. Acceleration metric (MSKAgeAccel/MSKAgeMortAccel) quantified deviations of biological age from chronological age, with positive values indicating accelerated musculoskeletal aging. Associations of MSKAgeAccel/MSKAgeMortAccel with mortality, musculoskeletal disorders, and age-related diseases were assessed using Cox proportional hazards models. Environmental and genetic determinants were evaluated by linear regression and genome-wide association analyses, respectively. Drug repurposing was used to identify potential targets of musculoskeletal diseases. A total of 39 musculoskeletal-related proteins constituted the pool. Leveraging these proteins, MSKAge (r = 0.62; r = 0.56) and MSKAgeMort (r = 0.93; r = 0.88) were constructed. Both MSKAgeAccel and (in particular) MSKAgeMortAccel predicted mortality, musculoskeletal diseases, and age-related diseases effectively. MSKAgeMortAccel showed significant associations with musculoskeletal disorders, including osteoarthritis, rheumatoid arthritis, gout, and low back pain. MSKAgeMortAccel was influenced by environmental pollutants, psychological factors, and unhealthy lifestyles. Genetic analyses revealed 13 variants and 71 genes enriched in epigenetic regulation and extracellular environment-receptor interaction. Zinc was identified as a candidate musculoskeletal drug. We established a reliable musculoskeletal aging clock and elucidated genetic and environmental determinants. This framework enables stratification of individuals at risk of accelerated musculoskeletal aging, paving the way for anti-aging interventions.

Why this matters

Organ-specific proteomic clocks like MSKAge push aging biomarkers beyond pan-tissue methylation estimators toward tissue-resolved risk stratification, and the musculoskeletal system is a domain where clinical outcomes (falls, sarcopenia, fracture) are concrete enough to test whether a clock adds signal over standard measures. The 39-protein panel also nominates candidate mediators for genetic and environmental drivers of MSK aging, though — like all clocks — its causal versus correlative status and responsiveness to intervention remain unestablished.

Source

Link

Briefing card

Construction and Validation of Plasma Protein-Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles.
Stage: observational · pubmed · 01-aug-2026

Two plasma protein-based musculoskeletal aging clocks (MSKAge and MSKAgeMort) built from 39 proteins in 21,070 UK Biobank participants predict mortality and musculoskeletal disease risk and identify genetic and environmental determinants of accelerated musculoskeletal aging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70636

build build 880 · 2bcef25 · 2026-11-18